Name | Number of supported studies | Average coverage | |
---|---|---|---|
natural killer cell | 3 studies | 17% ± 1% | |
CD4-positive, alpha-beta T cell | 3 studies | 19% ± 1% |
Insufficient scRNA-seq data for expression of CDCA5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 97% | 913.91 | 1746 / 1809 | 94% | 29.50 | 446 / 472 |
lung | 85% | 256.43 | 490 / 578 | 86% | 30.53 | 992 / 1155 |
intestine | 72% | 333.97 | 691 / 966 | 95% | 38.35 | 500 / 527 |
bladder | 67% | 91.90 | 14 / 21 | 93% | 37.14 | 467 / 504 |
stomach | 65% | 217.51 | 233 / 359 | 94% | 31.95 | 269 / 286 |
breast | 64% | 93.37 | 296 / 459 | 89% | 27.45 | 991 / 1118 |
esophagus | 57% | 404.16 | 830 / 1445 | 96% | 27.65 | 175 / 183 |
uterus | 53% | 69.26 | 90 / 170 | 98% | 52.59 | 451 / 459 |
ovary | 44% | 64.12 | 80 / 180 | 97% | 29.38 | 419 / 430 |
brain | 66% | 116.49 | 1740 / 2642 | 60% | 14.56 | 423 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 79.02 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 64.27 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 26.08 | 1 / 1 |
spleen | 100% | 790.42 | 240 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 75% | 137.50 | 193 / 258 | 20% | 4.33 | 46 / 230 |
prostate | 72% | 97.59 | 176 / 245 | 21% | 2.81 | 104 / 502 |
pancreas | 17% | 21.12 | 55 / 328 | 74% | 13.47 | 131 / 178 |
liver | 27% | 78.46 | 62 / 226 | 52% | 9.32 | 213 / 406 |
peripheral blood | 78% | 1512.32 | 723 / 929 | 0% | 0 | 0 / 0 |
kidney | 53% | 107.92 | 47 / 89 | 12% | 1.73 | 104 / 901 |
thymus | 47% | 60.49 | 306 / 653 | 16% | 7.76 | 97 / 605 |
adipose | 62% | 102.40 | 751 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 34% | 3.22 | 27 / 80 |
heart | 32% | 41.64 | 278 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 32% | 42.03 | 431 / 1335 | 0% | 0 | 0 / 0 |
muscle | 20% | 19.01 | 160 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007076 | Biological process | mitotic chromosome condensation |
GO_0051301 | Biological process | cell division |
GO_0000278 | Biological process | mitotic cell cycle |
GO_0007080 | Biological process | mitotic metaphase chromosome alignment |
GO_0031536 | Biological process | positive regulation of exit from mitosis |
GO_0007064 | Biological process | mitotic sister chromatid cohesion |
GO_0006302 | Biological process | double-strand break repair |
GO_0000775 | Cellular component | chromosome, centromeric region |
GO_0005694 | Cellular component | chromosome |
GO_0005829 | Cellular component | cytosol |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0005515 | Molecular function | protein binding |
GO_0003682 | Molecular function | chromatin binding |
Gene name | CDCA5 |
Protein name | Cell division cycle associated 5 Sororin (Cell division cycle-associated protein 5) (p35) |
Synonyms | |
Description | FUNCTION: Regulator of sister chromatid cohesion in mitosis stabilizing cohesin complex association with chromatin. May antagonize the action of WAPL which stimulates cohesin dissociation from chromatin. Cohesion ensures that chromosome partitioning is accurate in both meiotic and mitotic cells and plays an important role in DNA repair. Required for efficient DNA double-stranded break repair. . |
Accessions | H0YCZ9 Q96FF9 B5MBX0 ENST00000527430.1 ENST00000524733.5 H0YCT9 H0YCL8 ENST00000275517.8 H0YCR8 ENST00000404147.3 ENST00000525464.1 ENST00000529290.5 |